Conduct disorder
Conduct disorder
Conduct disorder
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Katerina Obo~ki<br />
What is the Practall and who perform it? Asthma experts ( number of 44 from two<br />
continents), Final work was published in Allergy, January 2008; Practall guidelines<br />
respect that patient – based practice is much more complicated than simply<br />
applying the available evidence to every patient equivalently; Practall uses common<br />
sense thinking by attempting to determine therapy based on diagnosis, as opposed<br />
to symptoms; Practall encourages the process of individualizing patient care by first<br />
improving pediatric asthma diagnosis; This involves: Differential Diagnosis<br />
Consideration, Phenotype-determining the type of asthma, Identification of<br />
comorbidities ; re-analysis of therapy approach.<br />
New Practall guidelines have to be with the pediatrician in mind! Asthma treatment<br />
should be Global- trigger avoidance, education of children and their surrounding,<br />
immunotherapy and monitoring are essential as pharmacotherapy. Inhaled steroids<br />
and LTRA are important tools in childhood asthma treatment, LABA only in severe<br />
persistent asthma. Phenotypes should be taken into account – steroids are more<br />
effective in atopic background, LTRA in young children with post viral asthma. The<br />
correct choice is individual – dependent on child and physician.<br />
Astmata e vode~ko hroni~no zaboluvawe vo mnogu industrijalizirani zemji.<br />
(1) Dokaznata osnova na specifi~nite aspekti na pedijatriskata astma, vkulu~uvaj]i<br />
ja i terapevtskata strategija e ograni~ena i nema skore[ni internacionalni<br />
vodi~i, koi se fokusirani posebno na decata pod pet godini.<br />
Prevalencata na astmata dramati~no raste vo poslednite 20 godini (1). Vo<br />
tek na edna godina, nasekade niz svetot, se referiraat 180 000 smrtni slu-<br />
~ai od astma.(2).<br />
Tro[ocite vo Evropa se slednive: 17,7 bilioni evra vo 2003 godina (9,8 bilioni<br />
evra vo pomalata produktivnost i 7,9 bilioni evra kako direktno<br />
medicinsko ~inewe)(3,4). Zgolemenata prevalenca na astmata vo poslednive<br />
dekadi e povrzana so zgolemuvaweto na atopiskata senzitizacija (pokraj<br />
drugite faktori) i alergiskite kondicii kako alergiski rinit (AR) i sinuzit,<br />
sugeriraj]i deka sistemskite komponenti na inflamacijata se asocirani<br />
so astmata (5,6). Dvaeset milioni Amerikanci imaat astma, vklu-<br />
~uvaj]i i 9 milioni deca, sekoj den 40 000 propu[teni rabotni i [kolski<br />
denovi, 30 000 egzacerbacii, 5000 urgentni poseti, 1000 hospitalizacii,<br />
11 smrtni slu~ai (7).<br />
Aktuelna situacija vo Evropa poka`uva deka vo poslednive godini, incidencata<br />
se zgolemuva 200%, pove]e od 10% od decata vo WHO EU regionot se<br />
zdobivaat so simptomi na astma, edno od naj~estite hroni~ni zaboluvawa po<br />
svojata kompleksnost i heterogenost, majoren globalen zdravstven problem,<br />
vku~uvaj]i go deteto, semejstvoto, zdravstveniot sistem i op[testvoto. Vo<br />
Страна 206